egf vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2015 (NCT02187367)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Epidermal growth factor receptorImmunity, active
Epidermal growth factor receptor immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- egf vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02187367 | Phase 3 | May 1, 2015 | Bioven, University of Aberdeen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bioven | For profit | 1 | 1 | 1 | 2015 |
| University of Aberdeen | Academic/Hospital | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1